54 results on '"Bonjardim, Leonardo R."'
Search Results
52. Characterization and Antihypertensive Effect of the Complex of (-)-β- pinene in β-cyclodextrin.
- Author
-
Moreira IJ, Menezes PP, Serafini MR, Araújo AA, Quintans-Júnior LJ, Bonjardim LR, Filho VJ, B P Júnior D, Santos SL, Júnior WL, Scotti L, Scotti MT, and Santos MR
- Subjects
- Animals, Antihypertensive Agents pharmacology, Arterial Pressure drug effects, Bicyclic Monoterpenes, Bridged Bicyclo Compounds chemistry, Bridged Bicyclo Compounds pharmacology, Calcium physiology, Endothelium, Vascular physiology, Hypertension physiopathology, Hypotension chemically induced, Male, Mesenteric Arteries drug effects, Mesenteric Arteries physiology, Monoterpenes chemistry, Monoterpenes pharmacology, Phenylephrine pharmacology, Rats, Wistar, Vasoconstrictor Agents pharmacology, Vasodilation drug effects, beta-Cyclodextrins chemistry, beta-Cyclodextrins pharmacology, Antihypertensive Agents therapeutic use, Bridged Bicyclo Compounds therapeutic use, Hypertension drug therapy, Monoterpenes therapeutic use, beta-Cyclodextrins therapeutic use
- Abstract
This work aimed to characterize and evaluate the antihypertensive effect of the (-)-β-pinene/β-cyclodextrin (βP/β-CD) complex. The complex was prepared through physical mixture and slurry complexation methods and was analyzed through differential scanning calorimetry, thermogravimetry/derivative thermogravimetry, fourier transform infrared spectroscopy, diffraction X-ray, docking and scanning electron microscopy. Normotensive or L-NAME-induced hypertensive rats were used in pharmacological experiments. Mean arterial pressure (MAP) was determined with direct blood pressure measurements from the abdominal aorta. The drugs were orally administrated and their effects were recorded during 48 hours. Vascular effects of βP were evaluated in isolated ring of mesenteric artery. The physicochemical characterization showed βP/β-CD complex formation. In hypertensive rats (MAP = 156±16 mmHg), the complex, but not βP alone, promoted hypotension at 36 and 48 hours after administration (MAP = 124±3 and 110±5 mmHg, respectively). In arterial rings, βP vasorelaxed rings precontracted with phenylephrine (Emax = 105±6%), which was not changed after the removal of the vascular endothelium (Emax = 108±4%), after the pre-contraction with KCl 80 mM (Emax = 107±8%) or S(-)-BayK8644 (Emax = 107±5%), or after incubation with TEA (Emax = 113±4%). Finally, βP inhibited CaCl2- and sodium-orthovanadate-induced contractions. In conclusion, the slurry complexation method was the best among them. Pharmacological results demonstrated that the complex promoted antihypertensive effect. Furthermore, βP induced endothelium- independent vasorelaxation possibly caused by the inhibition of the Ca2+ influx through L-type Ca2+ channel associated to a decrease in calcium sensitivity.
- Published
- 2016
- Full Text
- View/download PDF
53. Oral health, temporomandibular disorder, and masticatory performance in patients with Charcot-Marie-Tooth type 2.
- Author
-
Rezende RL, Bonjardim LR, Neves EL, Santos LC, Nunes PS, Garcez CA, Souza CC, and Araújo AA
- Subjects
- Brazil epidemiology, Bruxism etiology, Bruxism physiopathology, Charcot-Marie-Tooth Disease complications, Humans, Prevalence, Saliva chemistry, Temporomandibular Joint Disorders etiology, Temporomandibular Joint Disorders pathology, Bruxism epidemiology, Charcot-Marie-Tooth Disease epidemiology, Charcot-Marie-Tooth Disease physiopathology, Mastication physiology, Oral Health statistics & numerical data, Temporomandibular Joint Disorders epidemiology
- Abstract
Background: The aim of this study was to evaluate the oral health status of temporomandibular disorders (TMD) and bruxism, as well as to measure masticatory performance of subjects with Charcot-Marie-Tooth type 2 (CMT2)., Methods and Results: The average number of decayed, missing, and filled teeth (DMFT) for both groups, control (CG) and CMT2, was considered low (CG = 2.46; CMT2 = 1.85, P = 0.227). The OHIP-14 score was considered low (CG = 2.86, CMT2 = 5.83, P = 0.899). The prevalence of self-reported TMD was 33.3% and 38.9% (P = 0.718) in CG and CMT2 respectively and for self-reported bruxism was 4.8% (CG) and 22.2% (CMT2), without significant difference between groups (P = 0.162). The most common clinical sign of TMD was masseter (CG = 38.1%; CMT2 = 66.7%) and temporalis (CG = 19.0%; GCMT2 = 33.3%) muscle pain. The geometric mean diameter (GMD) was not significantly different between groups (CG = 4369; CMT2 = 4627, P = 0.157)., Conclusion: We conclude that the CMT2 disease did not negatively have influence either on oral health status in the presence and severity of TMD and bruxism or on masticatory performance.
- Published
- 2013
- Full Text
- View/download PDF
54. Antinociceptive activity of atranorin in mice orofacial nociception tests.
- Author
-
Siqueira RS, Bonjardim LR, Araújo AA, Araújo BE, Melo MG, Oliveira MG, Gelain DP, Silva FA, DeSantana JM, Albuquerque-Júnior RL, Rocha RF, Moreira JC, Antoniolli AR, and Quintans-Júnior LJ
- Subjects
- Allergens pharmacology, Animals, Carrageenan, Edema chemically induced, Edema drug therapy, Facial Pain chemically induced, Facial Pain drug therapy, Hydroxybenzoates chemistry, Hydroxybenzoates therapeutic use, Hypnotics and Sedatives pharmacology, Male, Mice, Morphine pharmacology, Morphine therapeutic use, Neuromuscular Depolarizing Agents pharmacology, Plant Extracts pharmacology, Plant Extracts therapeutic use, Rotarod Performance Test, Hydroxybenzoates pharmacology, Pain drug therapy, Pain Measurement drug effects
- Abstract
Physicochemical characterization and antinociceptive and anti-inflammatory activities of atranorin (AT) extracted from Cladina kalbii Ahti in formalin- and capsaicin-induced orofacial pain and anti-inflammatory tests in rodents were studied. Physicochemical characterization showed that AT has the general formula C19H18O8. Male Swiss mice were pretreated with AT (100, 200, and 400 mg/kg, i.p.), morphine (3 mg/kg, i.p.), or vehicle (0.9% saline with two drops of 0.2% Tween 80) before formalin (20 microl, 2%) or capsaicin (20 microl, 2.5 microg) were injected into the right vibrissa. Our results showed that i.p. treatment with AT displayed marked inhibitory effects in different orofacial pain tests in mice. AT (400 mg/kg, i.p.) was effective in reducing the nociceptive face-rubbing behavioural response in both phases of the formalin test, which was also naloxone-sensitive. Additionally, AT produced a significant antinociceptive effect at all doses in the capsaicin test. Such results were unlikely to be provoked by motor abnormality, since AT-treated mice exhibited no performance alteration on the rota rod apparatus. AT exhibited significant anti-inflammatory activity in the acute model of inflammation (leukocyte migration to the peritoneal cavity), carrageenan- and arachidonic acid-induced hind paw edema in rats. Additionally, AT exhibited a dose-dependent antioxidant activity in vitro, as assessed by total radical-trapping antioxidant parameter and total antioxidant reactivity assays. All these findings suggest that AT might represent an important tool for the management of orofacial pain and/or inflammatory disorders.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.